NASDAQ · VLXVX
Vanguard Target Retirement 2065 Fund
$44.71-$0.07 (-0.16%)
Vanguard Target Retirement 2065 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.4% below the high.
Loading market information…
NASDAQ · PRHSX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
T. Rowe Price Health Sciences Fund’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
T. Rowe Price Health Sciences Fund’s forward annual dividend is $10.10 per share, paid annual. The forward yield is 10.02% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund typically allocates a minimum of 80% of its total net assets (including any borrowed capital utilized for investment purposes) to the common stock shares of businesses within the health sciences domain. This includes companies focused on the research, development, manufacturing, or distribution of offerings related to healthcare, medicine, or the broader life sciences. While the portfolio has the liberty to invest in companies of any market capitalization, most of its holdings are projected to be in large- and medium-sized corporations. The fund operates as a non-diversified investment vehicle.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:14 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$44.71-$0.07 (-0.16%)
Vanguard Target Retirement 2065 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.4% below the high.
$580.12-$1.77 (-0.3%)
State Street Equity 500 Index Fund’s quoted price sits in the upper half of its reported 52-week range, 1.22% below the high.
$93.56-$0.31 (-0.33%)
Victory 500 Index Fund’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
$37.25+$0.62 (+1.69%)
T. Rowe Price Mid-Cap Value Fund’s quoted price sits in the upper half of its reported 52-week range, 2.92% below the high.
$22.64-$0.14 (-0.61%)
T. Rowe Price International Stock’s quoted price sits in the upper half of its reported 52-week range, 6.48% below the high.
$52.75+$0.76 (+1.46%)
Allspring Special Mid Cap Value Fund’s quoted price sits in the upper half of its reported 52-week range, 0.06% below the high.
$53.54+$0.77 (+1.46%)
Allspring Special Mid Cap Value R6’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$21.01+$0.01 (+0.05%)
T. Rowe Price Retirement 2020 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.55% below the high.
